| |
| Device | PROPEL MINI SINUS IMPLANT |
| Generic Name | Drug-eluting sinus stent |
| Applicant | Intersect Ent. 1555 Adams Dr. Menlo Park, CA 94025 |
| PMA Number | P100044 |
| Supplement Number | S018 |
| Date Received | 09/25/2015 |
| Decision Date | 03/23/2016 |
| Product Code |
OWO |
| Docket Number | 16M-1123 |
| Notice Date | 04/12/2016 |
| Advisory Committee |
Ear Nose & Throat |
| Clinical Trials | NCT02266810
|
| Supplement Type | Panel Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | Yes |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for the PROPEL Mini Sinus Implant is intended for use in patients >= 18 years of age following ethmoid/frontal sinus surgery to maintain patency of the ethmoid sinus or frontal sinus opening. The PROPEL Mini Sinus Implant separates/dilates surrounding mucosal tissues, provides stabilization of the middle turbinate, prevents obstruction by adhesions, and reduces inflammation. The implant reduces the need for post-operative intervention such as surgical adhesion lysis and/or use of oral steroids. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling
|